Natco Pharma Limited has informed the Exchange regarding 'Sustainability Report for the year 2024-25'.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has filed its Sustainability Report for FY 2024-25 with the stock exchanges, prepared per GRI Standards 2021 and aligned with SEBI's BRSR framework. The report highlights strong financial performance with total revenue of ₹47,840 million (up from ₹41,269 million) and profit after tax of ₹18,834 million (up from ₹13,883 million), alongside an EBITDA margin of 53.30%. On ESG metrics, the company reports that 25% of its electricity and 13% of total energy came from renewable sources, 53% of water was recycled, and R&D spend stood at ₹3,733 million. Targets include 35% renewable energy by 2035, carbon neutrality by 2050, and water neutrality at API units by FY 2025-26. The company remains debt-free with zero customer complaints on data privacy and cybersecurity.
This is a routine regulatory disclosure of the company's annual sustainability/ESG report and is unlikely to move the stock price on its own. However, it reinforces Natco's strong financial trajectory and growing ESG credentials, which may appeal to long-term, sustainability-focused investors.